Cargando…
The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who Underwent Heart or Lung Transplantation in New Orleans, USA Between 2013 and 2019: A Single-Center Retrospective Study
BACKGROUND: Tacrolimus, a calcineurin inhibitor, is the cornerstone of immunosuppressive strategies in transplantation. Other studies have concluded that hyperkalemia correlates with tacrolimus therapy, though the impact is poorly understood. In 2 separate analyses, the aim of this study was to inve...
Autores principales: | Griffis, Olivia L., Thai, Steven Q., Allison, Cody, Baetz, Brooke, Mohammed, Alaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357348/ https://www.ncbi.nlm.nih.gov/pubmed/35915576 http://dx.doi.org/10.12659/AOT.935607 |
Ejemplares similares
-
Pittsburgh Conference, New Orleans, USA, 1988
Publicado: (1988) -
High Blood Tacrolimus and Hyperkalemia in a Heart Transplant Patient
por: Sahu, Manoj Kumar, et al.
Publicado: (2017) -
The Association between CDKAL1 Gene rs10946398 Polymorphism and Post-Transplant Diabetes in Kidney Allograft Recipients Treated with Tacrolimus
por: Dziedziejko, Violetta, et al.
Publicado: (2023) -
Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008) -
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)